The rate-limiting enzyme in the kynurenine pathway, indoleamine 2,3-dioxygenase (IDO), is upregulated in the AD brain and promotes the conversion of tryptophan into quinolinic acid (QA) [215, 218]. The gene discussed is IDO1; the disease is Alzheimer disease.